Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Seth Woodruff"'
Autor:
Afua Richardson-Parry, Carole Baas, Shaantanu Donde, Bianca Ferraiolo, Maimah Karmo, Zorana Maravic, Lars Münter, Ignacio Ricci-Cabello, Mitchell Silva, Stacey Tinianov, Jose M. Valderas, Seth Woodruff, Joris van Vugt
Publikováno v:
International Journal for Equity in Health, Vol 22, Iss 1, Pp 1-9 (2023)
Abstract Background Health inequities lead to low rates of cancer screening in certain populations, such as low-income and ethnic minority groups. Different interventions to address this have been developed with mixed results. However, interventions
Externí odkaz:
https://doaj.org/article/9b55d5a0ab284a07a69117d082e042d9
Autor:
Afua Richardson-Parry, Mitchell Silva, Jose M. Valderas, Shaantanu Donde, Seth Woodruff, Joris van Vugt
Publikováno v:
European Journal of Cancer Prevention.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f4e54362ef60f6b16552d0c22ef149b
https://doi.org/10.1097/cej.0000000000000796
https://doi.org/10.1097/cej.0000000000000796
Autor:
Seth Woodruff, MD
In this paper, A Single Origin of Life and Death on Earth Hypothesis (SOLDE) is introduced that links salicylic acid (SA) to both the origin of life and aging. SOLDE predicts the existence of an as-yet-undefined, universally conserved, novel molecula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a993338342e0eece873f222fa41c0b16
https://doi.org/10.31219/osf.io/7eujz
https://doi.org/10.31219/osf.io/7eujz
Autor:
Seth Woodruff
Mitochondria may have been retained in eukaryotes in large part because of their capacity to both fuel and catalyze the evolution of species by means of natural selection. After billions of years of evolution, perhaps eukaryotes have improved enough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f866c2c3f45324f94bbb6e36d3c59df
https://doi.org/10.31219/osf.io/dvurx
https://doi.org/10.31219/osf.io/dvurx
Publikováno v:
Journal of Thrombosis and Thrombolysis
In patients with active cancer and acute venous thromboembolism (VTE), the low-molecular-weight-heparin (LMWH) dalteparin is more effective than vitamin K antagonist (VKA) in reducing the risk of recurrent venous thromboembolism (rVTE) without increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2343f004a2de48e0715ed05008d5cacb
http://europepmc.org/articles/PMC6476994
http://europepmc.org/articles/PMC6476994
Publikováno v:
Journal of Oncology Pharmacy Practice
BackgroundPatients with cancer have an elevated risk of venous thromboembolism. Importantly, patients with cancer, who have metastatic disease, renal insufficiency, or are receiving anticancer therapy, have an even higher risk of a recurrent event. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9348e4f24450b8b9d6fc16343529c801
https://doi.org/10.1177/1078155217727140
https://doi.org/10.1177/1078155217727140
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
George Dranitsaris,1 Lesley G Shane,2 Mark Crowther,3 Guillaume Feugere,4 Seth Woodruff2 1Health Economic and Outcomes Research, Augmentium Pharma Consulting Inc, Toronto, ON, Canada; 2Pfizer Inc, New York, NY, USA; 3McMaster University, Hamilton, ON
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7209bb89afd5bb140d653e21d2ddf95e
https://www.dovepress.com/dalteparin-versus-vitamin-k-antagonists-for-the-prevention-of-recurren-peer-reviewed-article-CEOR
https://www.dovepress.com/dalteparin-versus-vitamin-k-antagonists-for-the-prevention-of-recurren-peer-reviewed-article-CEOR
Autor:
Seth Woodruff, Lesley G Shane, Gunar Stemer, Jean-Philippe Galanaud, Philippe Debourdeau, George Dranitsaris
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 25(7)
International guidelines recommend extended duration secondary prophylaxis in cancer patients who develop primary venous thromboembolism (VTE). Agent selection is guided in part by one large randomized trial (i.e., CLOT; Lee et al., N Engl J Med 349:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2729a659aca81719fc491b47048a05fb
https://pubmed.ncbi.nlm.nih.gov/28204995
https://pubmed.ncbi.nlm.nih.gov/28204995
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 22(7)
Background: In a randomized trial (ie, Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer [CLOT]) that evaluated secondary prophylaxis of recurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685a4d7f5eff78cb00217e8e4f39f4c4
https://pubmed.ncbi.nlm.nih.gov/27436663
https://pubmed.ncbi.nlm.nih.gov/27436663
Autor:
Michael Pinkawa, Daniela Piroth, Richard Holy, Michael J. Eble, Seth Woodruff, Marc D. Piroth
Publikováno v:
Strahlentherapie und Onkologie. 185:669-674
Timing and sequencing of radiotherapy in the context of allogenous breast reconstruction have not been standardized. The aim of the present study was to assess the influence of adjuvant radiotherapy on morbidity and patient satisfaction after allogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09a94e583f194501bb5d9add654f51f
https://doi.org/10.1007/s00066-009-2013-9
https://doi.org/10.1007/s00066-009-2013-9